TCL Archive “Absurd” Budget Cuts Would Devastate Cancer Program, Slash NCI Funds By $125 Million December 6, 1974
TCL Archive FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug July 26, 2013